Veronika Viktorija Borutinskaite (Veronika Borutinskaitė)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Indre Krastinaite, Sergej Charkavliuk, Rūta Navakauskienė, Veronika Viktorija Borutinskaite
Metformin as an Enhancer for the Treatment of Chemoresistant CD34+ Acute Myeloid Leukemia Cells. Genes 15 (5) (2024)
Indre Krastinaite, Sergej Charkavliuk, Rūta Navakauskienė, Veronika Viktorija Borutinskaite
Metformin as an Enhancer for the Treatment of Chemoresistant CD34+ Acute Myeloid Leukemia Cells. Genes 15 (5) (2024)
Indre Krastinaite, Sergej Charkavliuk, Rūta Navakauskienė, Veronika Viktorija Borutinskaite
Metformin as an Enhancer for the Treatment of Chemoresistant CD34+ Acute Myeloid Leukemia Cells. Genes 15 (5) (2024)
Aida Vitkevičienė, Giedrė Skiauterytė, Andrius Žučenka, Mindaugas Stoškus, Eglė Gineikienė, Veronika Viktorija Borutinskaite, Laimonas Griškevičius, Rūta Navakauskienė
Corrigendum to "HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia". Journal of oncology 2020 (2020)
Aida Vitkevičienė, Giedrė Skiauterytė, Andrius Žučenka, Mindaugas Stoškus, Eglė Gineikienė, Veronika Viktorija Borutinskaite, Laimonas Griškevičius, Rūta Navakauskienė
HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia. Journal of oncology 2019 (2019)